Related Experiment Video

Updated: May 16, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

The relationship between microalbuminuria, cardiovascular risk factors and disease management in type 2 diabetes

I C Udenze1, E C Azinge, O A T Ebuehi

  • 1Department of Clinical Pathology, College of Medicine, University of Lagos, Lagos, Nigeria. ifeomaudenze@yahoo.com

Nigerian Quarterly Journal of Hospital Medicine
|November 27, 2012
PubMed
Abstract

Insights

Microalbuminuria is common in type 2 diabetes, affecting 24% of patients. Key risk factors include longer diabetes duration, hypertension, obesity, and poor glycemic control, highlighting the need for better cardiovascular risk management.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Microalbuminuria is an early indicator of glomerular vascular damage in type 2 diabetes.
  • It is a significant risk factor for cardiovascular disease in this population.

Purpose of the Study:

  • Determine the prevalence of microalbuminuria in type 2 diabetes.
  • Identify risk factors associated with microalbuminuria.
  • Assess the achievement of cardiovascular risk reduction treatment goals.

Main Methods:

  • Recruited 72 microalbuminuric patients from 300 screened type 2 diabetics.
  • Collected clinical data via interviews and anthropometric measurements.
  • Analyzed blood specimens for relevant biomarkers.

Main Results:

  • Prevalence of microalbuminuria was 24% in type 2 diabetes.
  • Independent risk factors identified: diabetes duration, hypertension, BMI, WHR, and HbA1c.
  • Optimal control achieved: 85% for blood pressure, 58% for glycemic, 19% for weight.

Conclusions:

  • Microalbuminuria is prevalent in type 2 diabetes patients.
  • Observed improvements in glycemic control and modifiable cardiovascular risk factors compared to prior studies.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...